1) dynamic line enhancer
动态谱增强
2) dynamic enhancement
动态增强
1.
[Methods] Collected and analyzed to the spiral CT dynamic enhancement findings and it's routine scan findings of 30 lung cancer nodule cases,observe the CT values of the primary affection in each time,and draw dynamic enhancement time-density curves.
[方法]对比分析30例肺癌结节患者的螺旋CT动态增强扫描及自身CT平扫,重点观察原发灶动态增强各时相的CT值,根据CT值绘出动态增强曲线。
2.
Objective To study the relationship between MSCT peak dynamic enhancement ratio in arterial phase and the grade of cell differentiation,MVD,VEGF,CD34 expressions of HCC, and to evaluate the tumor angiogenesis in hepatocellular carcinoma and provide a foundation to treatment and predicting prognosis of HCC.
方法手术病理证实的30例肝癌患者,术前分别应用16层CT的Testblous序列进行同层动态增强扫描,术后肿瘤标本行HE染色及免疫组化分析。
3.
All cases were performed dynamic enhancement scanning on 3.
目的:探讨离子型和非离子型MR对比剂在MR颈动脉动态增强扫描中的应用价值。
3) dynamic contrast enhancement
动态增强
1.
MRI with multiple contrast weightings and dynamic contrast enhancement in evaluation of vulnerable atherosclerotic plaques;
MRI多序列与动态增强扫描对动脉易损斑块的评估
4) Dynamic contrast-enhanced
动态增强
1.
Dynamic contrast-enhanced MRI of breast disease: correlation of MR findings with vascular endothelial growth factor and microvessel density;
乳腺良恶性病变动态增强MRI与血管内皮生长因子及微血管密度相关性的研究
2.
Value of DWI and dynamic contrast-enhanced MRI in differential diagnosis of lymph node lesions
DWI及动态增强MRI在淋巴结病变鉴别诊断中的价值
3.
Objective To evaluate the role of conventional spin echo(SE) and dynamic contrast-enhanced(DCE) MR imaging with high magnetic field in renal cell carcinoma(RCC) in comparison with helical CT.
目的 比较高场强MRI与螺旋CT平扫与动态增强检查对肾癌的诊断价值。
6) Dynamic contrast-enhanced MRI
动态增强MRI
1.
PURPOSE: To observe the correlation of dynamic contrast-enhanced MRI (DCE-MRI) appearances, and microvessel density(MVD) , vascular endothelial growth factor(VEGF) expressions,and the blood stasis syndrome in breast cancer.
目的探讨乳腺癌动态增强MRI与微血管密度(MVD)、血管内皮生长因子(VEGF)及中医血瘀证之间的关系,为术前评价乳腺癌的预后及指导中西医综合治疗提供客观依据。
补充资料：动态增强磁共振血管成像
动态增强磁共振血管成像
磁共振成像术语。静脉注射顺磁性对比剂以缩短血流T1值、显示血管影像的MR成像方法。和传统的、不使用对比剂的磁共振血管成像(MRA)方法(时飞法、相位对比法和黑血法)不同，动态增强MRA利用注射入血液的对比剂使血流的T1值比周围组织(包括脂肪组织)还要短，从而得到血管的显示。动态MRA可用2D或3D技术采集；需选择可获得最佳血液/背景组织对比的翻转角；需应用常规的2～4倍的对比剂剂量(0.2～0.4mmol/kg)及在尽可能短的时间内完成数据采集，并在扫描前期或扫描全程快速、稳定地注射对比剂。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条